Clariance ErYs Registry

计划入组 760 人 · 首次发布于 2021 年 12 月 28 日

A Study to Assess the Pharmacokinetics and Safety of Different Forms and Formulations of AZD9496 in Healthy Subjects

计划入组 14 人 · 首次发布于 2016 年 5 月 23 日

Cardioneuroablation for Variant Angina

计划入组 16 人 · 首次发布于 2025 年 5 月 28 日

Sargramostim biosimilar(Clariant AG)

Pegfilgrastim(Fulphila, Fylnetra, Neulasta, Udenyca, Ziextenzo, Cegfila (previously Pegfilgrastim Mundipharma), Nyvepria, Pelgraz, Grasustek, Pelmeg, Stimufend, Dyrupeg)

Sugaheal variant

Clariance

Luxembourg

CLARIGENT HEALTH

United States

AZIENDA SOCIO SANITARIA TERRITORIALE LARIANA

Italy

Clariant Establishes First US Manufacturing Site for Pharmaceutical-Grade PEG Excipients in Texas

U.S. Desiccants Market Projected to Reach $565.78 Million by 2035, Driven by Pharmaceutical and Biologics Packaging Demand

Mitochondrial DNA Variant Predicts Immunotherapy Resistance in Metastatic Melanoma